Skip To Main Content
byElena Schmidt on Muck Rack

byElena Schmidt

As seen in: Psychedelic Spotlight
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with byElena

Contact byElena, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

10 Key 2023 Psychedelic Studies Reveal Optimal Psilocybin Doses for Depression

|
By byElena Schmidt, Elena Schmidt
| Psychedelic Spotlight
Psychedelic research is flourishing again, and mainstream Americans may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new drug application submission. And psilocybin is not far behind. 2023 psychedelic research success means psilocybin could be legal therapeutically in a few short years. The latest studies show that 12 to 25 mg psilocybin doses for depression is sufficient for most patients.
Open in Who Shared Issue with article?

Psychedelic Holiday Gift Guide 2023: 11 Ideas for Your Favorite Soul Seekers

|
By byElena Schmidt, Elena Schmidt
| Psychedelic Spotlight
Ready to step outside the box and embrace the unconventional? This year's holiday gift guide celebrates psychedelics and nods to those who appreciate the profound and the extraordinary. From thought-provoking reads to journals that capture the essence of mind-bending trips, this selection speaks directly to soul-seekers and plant lovers. Explore energizing culinary experiences. Consider skincare with an adaptogenic twist. Optimize your loved one’s health with nootropics.
Open in Who Shared Issue with article?

10 Key 2023 Psychedelic Studies Reveal Optimal Psilocybin Doses for Depression

|
By byElena Schmidt, Elena Schmidt
| Psychedelic Spotlight
Psychedelic research is flourishing again, and mainstream Americans may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new drug application submission. And psilocybin is not far behind. 2023 psychedelic research success means psilocybin could be legal therapeutically in a few short years. The latest studies show that 12 to 25 mg psilocybin doses for depression is sufficient for most patients.
Open in Who Shared Issue with article?
See all 9 articles